Primary Site >> Colorectal Cancer
Gene >> TPM3
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: The trk family of oncogenes and neurotrophin receptors. PMID: 1844238 |
Ref: Externalization of tropomyosin isoform 5 in colon epithelial cells. PMID: 10540182 |
Ref: Isolation and sequencing of a novel tropomyosin isoform preferentially associated with colon cancer. PMID: 12105844 |
Ref: Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer. PMID: 18710659 Ref: Ileal lesions in patients with ulcerative colitis after ileo-rectal anastomosis: relationship with colonic metaplasia. PMID: 18785281 |
Ref: Mesalamine suppresses the expression of TC22, a novel tropomyosin isoform associated with colonic neoplasia. PMID: 19369484 |
Ref: The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition. PMID: 24962792 |
Ref: Label-free quantitative mass spectrometry reveals a panel of differentially expressed proteins in colorectal cancer. PMID: 25699276 Ref: Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma. PMID: 26001971 Ref: Crucial role of the orexin-B C-terminus in the induction of OX1 receptor-mediated apoptosis: analysis by alanine scanning, molecular modelling and site-directed mutagenesis. PMID: 26282891 Ref: NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line. PMID: 26472021 |
Ref: Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer. PMID: 26563355 Ref: NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer. PMID: 26716414 |
Ref: Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions. PMID: 28719467 Ref: Mechanisms of Resistance to NTRK Inhibitors and Therapeutic Strategies in NTRK1-Rearranged Cancers. PMID: 28751539 Ref: In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs. PMID: 29125233 |
Ref: A novel in-cell ELISA method for screening of compounds inhibiting TRKA phosphorylation, using KM12cell line harboring TRKA rearrangement. PMID: 29360440 Ref: Foretinib Overcomes Entrectinib Resistance Associated with the NTRK1 G667C Mutation in NTRK1 Fusion-Positive Tumor Cells in a Brain Metastasis Model. PMID: 29463555 |